Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

The BMJ weighs in on Avastin/Lucentis debate

The BMJ weighs in on Avastin/Lucentis debate ahead of Lucentis and Eylea for years, predominately because it is around a tenth of the price of the licensed medicines. ... In fact, Roche co-markets Lucentis with Novartis in certain markets as Lucentis is the 'chemical cousin' of Avastin.

Bayer's Eylea cleared for wider use in Europe

Bayer's Eylea cleared for wider use in Europe population. Eylea was approved to treat DME in the US last July and in Europe the following month, while Lucentis has had that indication on its label since 2012. ... Lucentis' growth this year - with the potential for flat or even a modest decline in

UK doctors call on NHS to use Avastin for wet AMD

UK doctors call on NHS to use Avastin for wet AMD Avastin only has cancer licences, but it is chemically similar to Lucentis, meaning it can be successfully used for wet AMD. ... In fact, Roche co-markets Lucentis with Novartis in certain markets as Lucentis is the 'chemical cousin' of Avastin. .

NICE recommends Ozurdex for diabetic eye condition

NICE recommends Ozurdex for diabetic eye condition The eye indication was approved for DMO in the EU in September of last year, setting it up as competition against Novartis' blockbuster eye drug  Lucentis(ranibizumab) as well as

Fresh approval for Roche's Lucentis as competition heats up

Fresh approval for Roche's Lucentis as competition heats up Approved for more diabetes-related eye complications.  . Roche has won FDA approval for Lucentis as a treatment for eye complications in more people with diabetes, boosting the target population of the ... The FDA previously had approved Lucentis to

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics